Pattern of Upper Gastrointestinal Lesions in Upper Egypt : Clinical, Endoscopic and Pathological Evaluation
1 other identifier
observational
100
0 countries
N/A
Brief Summary
Upper Gastrointestinal (UGI) symptoms are among the commonest complaints for which patients seek medical attention, with the annual prevalence of dyspepsia approximating 25% . Endoscopy holds an important place in the diagnosis of UGI conditions by enabling visualization, photography, ultrasonography, and biopsying of suspicious lesions . It gives a better diagnostic yield over radiology particularly in the investigation of upper gastrointestinal bleeding, inflammatory conditions of the upper gastro-intestinal track like esophagitis, gastritis and duodenitis as well as the diagnosis of Mallory Weiss tears and vascular malformations .Dyspepsia in the absence of any other symptom was the indication for UGIE in the vast majority of patients. Close to 80% of our patients presented with dyspepsia not associated with any other symptom and in 50% of the patients the endoscopic findings were normal \[4\]. Other common reasons for UGIE were GERD symptoms, recurrent vomiting, dyspepsia associated with weight loss and patients with symptoms of UGI bleeding . Gastritis was the most frequent endoscopic finding in our patients, followed by duodenitis .Gastric ulcer was diagnosed more frequently than duodenal ulcers . Taking a biopsy is very helpful in diagnosis in our study. H. pylori colonization of the gut is the main cause of chronic gastritis and the principal etiological agent of gastric cancer and peptic ulcer disease . Gastric cancer was diagnosed, by endoscopy, about eight times more frequently in patients presenting with an alarm symptom like recurrent vomiting, dyspepsia together with weight loss or UGI bleeding .
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2020
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 28, 2020
CompletedStudy Start
First participant enrolled
March 30, 2020
CompletedFirst Posted
Study publicly available on registry
March 31, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2021
CompletedMarch 31, 2020
March 1, 2020
1 month
March 28, 2020
March 28, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Pattern of upper gastrointestinal lesions
We will see what common GIT lesions happen in patients of upper Egypt
1 year
Interventions
Diagnostic upper Git endoscopy
Eligibility Criteria
All patient undergoing elective and urgent upper GIT endoscopy either therapeutic or diagnostic. In elrajhi endoscopy unit
You may qualify if:
- \- All patient undergoing elective and urgent upper GIT endoscopy either therapeutic or diagnostic.
You may not qualify if:
- Patient undergoing endoscopic intervention for previously detected endoscopic lesion
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- RHMHasanen
Study Record Dates
First Submitted
March 28, 2020
First Posted
March 31, 2020
Study Start
March 30, 2020
Primary Completion
May 1, 2020
Study Completion
April 30, 2021
Last Updated
March 31, 2020
Record last verified: 2020-03